Story

Kinder Morgan Options Market Braces for 2.2% Post-Earnings Move

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Kinder Morgan Options Market Braces for 2.2% Post-Earnings Move

Summary

Options traders are pricing in a potential 2.2% stock price swing for Kinder Morgan following its earnings release on July 22. Historical data shows the energy infrastructure company's stock has exceeded the options-implied move in five of the last eight quarters.

Text size
Background

The options market is anticipating a 2.2% move in either direction for Kinder Morgan Inc. (KMI) shares following the company's upcoming earnings announcement on July 22. This forecast is based on options data compiled by Bloomberg and reflects traders' consensus on potential post-earnings volatility.

Historical Volatility vs. Expectations

A review of the past eight earnings reports shows that Kinder Morgan's stock has frequently experienced larger price swings than the options market had priced in. The actual share price movement surpassed the implied move in five of those eight instances.

This pattern suggests the market has historically underestimated the stock's reaction to earnings news. Notable examples of this disparity include:

  • January 2026: An actual move of 8.4% versus an implied move of just 1.3%.
  • April 2025: An actual move of 7.5% compared to an implied 1.7%.
  • October 2024: An actual move of 6.4% against an implied 2.4%.
Sample IUX Markets – In-articleAd

Market Implications

The implied move is derived from the pricing of options contracts, specifically at-the-money straddles, and serves as a key gauge of expected volatility. While not a prediction of direction, it indicates the magnitude of the price change anticipated by the market.

For investors, the historical tendency for Kinder Morgan's stock to move more than implied could suggest a potential for heightened volatility around the July 22 release. The most recent report in April was an exception, with the stock moving 0.3% against an implied 0.9%, according to the data.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST